Earnings per share (EPS) is a key financial indicator that investors use to gauge a company's profitability. A higher than expected EPS is typically seen as a positive sign and can lead to an increase in stock price in the short term. Since AEON Biopharma has reported its earnings with an EPS of $1.19, this could be perceived as a positive outcome, potentially leading to a bullish sentiment among investors.